Cohen et al, Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series, Communications Medicine (2025). DOI: 10.1038/s43856-024-00668-8 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback